[2] Yan K, Li F, Bi X, Han L, et al. Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2024...
,美国皮肤病学会成立于 1938 年,总部位于伊利诺伊州罗斯蒙特,是所有皮肤病学会中规模最大、最具影响力和最具代表性的学会。AAD 在全球拥有超过 20,500 名医生,致力于:推进皮肤、头发和指甲的诊断和内科、外科和美容治疗;倡导皮肤病学临床实践、教育和研究的高标准;并支持和加强患者护理,使皮肤、头发和指甲终生更...
参考文献: [1] Zhang Jianzhong.Long-term Efficacy and Safety of SHR0302 in Patients with Moderate-to-Severe Atopic Dermatitis:52-Week Results from a Phase 3 Study.AAD 2023 Annual Meeting; March 8-12. (Oral presentation). [2]Faye O, Flohr C, Kabashima K, et al. Atopic dermatitis: A gl...
Frank. They provided an overview of the department, explained the importance of the meeting, and outlined the responsibilities of the executives within the department. They also highlighted the achievements of the 2023/24 academic year...
[6] AAD 2023 Annual Meeting; March 17-21. (Oral presentation). 声明: 1. 本新闻旨在分享研发前沿资讯,仅供医疗卫生专业人士基于学术目的参阅,非广告用途。 2.恒瑞医药不推荐任何未被批准的药品、适应症的使用。 撰稿:中央市场五部 排版:马瑞璘
[3] AAD 2023 Annual Meeting; March 17-21. (Oral presentation). 声明: 1.本新闻旨在分享学术前沿动态,仅供医疗卫生专业人士基于学术目的参阅,非广告用途。 2.恒瑞医药不对任何药品和/或适应症作推荐。 3.本新闻中涉及的信息仅供参考,请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何...
[6] AAD 2023 Annual Meeting; March 17-21. (Oral presentation). 声明: 1. 本新闻旨在分享研发前沿资讯,仅供医疗卫生专业人士基于学术目的参阅,非广告用途。 2. 恒瑞医药不推荐任何未被批准的药品、适应症的使用。 撰稿:中央市场五部 排版:马瑞璘
[6] AAD 2023 Annual Meeting; March 17-21. (Oral presentation). 声明: 1. 本新闻旨在分享研发前沿资讯,仅供医疗卫生专业人士基于学术目的参阅,非广告用途。 2. 恒瑞医药不推荐任何未被批准的药品、适应症的使用。
1.Gooderham M, et al. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with Chronic Hand Eczema: results of the Phase 3 open-label extension DELTA-3 trial. Presented at the 2024 American Academy of Dermatology Annual Meeting;March 8-12 2024;San Diego, ...
[1] Zhang Jianzhong.Long-term Efficacy and Safety of SHR0302 in Patients with Moderate-to-Severe Atopic Dermatitis:52-Week Results from a Phase 3 Study.AAD 2023 Annual Meeting; March 8-12. (Oral presentation). [2]Faye O, Flohr C, Kabashima K, et al. Atopic dermatitis: A global health...